DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Anthracycline
Anthracycline
And Cisplatin-Resistant Ovarian Cancer
5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells
Cardioprotective Effects of Exercise Training on Doxorubicin-Induced
Anticancer Drugs
Characterization of the Small Molecule Kinase Inhibitor SU11248 (Sunitinib/ SUTENT in Vitro and in Vivo
Anthracycline Chemotherapy and Cardiotoxicity
Identification and Validation of an Anthracycline/ Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer Jude M
Caelyx, INN-Doxorubicin Hydrochloride
Lists of Medicinal Products for Rare Diseases in Europe*
A Unified Definition of Clinical Anthracycline Resistance Breast
Control of Nausea and Vomiting in Patients Receiving Anthracycline
Derivation of Anthracycline Equivalence to Doxorubicin in Relation to Late Cardiotoxicity: Epirubicin, Idarubicin and Mitoxantrone
Platinum-Based Agent and Fluorouracil
Anthracycline‑Induced Cardiotoxicity in the Chemotherapy Treatment of Breast Cancer: Preventive Strategies and Treatment (Review)
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
Targeting DNA with Anthracyclines: the Importance of the Sugar Moiety
A Novel Anti-HER2 Anthracycline-Based Antibody-Drug
Anthracyclines: Cardiotoxicity and Its Prevention
Top View
Do Not Administer Doxorubicin Hcl in Combination with Trastuzumab
Management of Cardiac Toxicity Induced by Chemotherapy
Benzyladriamycin-14-Valerate with the C1-Regulatory Domain of Protein Kinase C: Structural Requirements, Isoform Specificity, and Correlation with Drug Cytotoxicity1
Important Drug Information
Anthracyclines
Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients Thomas D
Facile Formation of a Crosslinked Adduct Between DNA And
Review of Medicines for the Treatment of Common Tumours in Children
NCCP Chemotherapy Regimen
Tyrosine Kinase Inhibition to Improve Anthracycline-Based Chemotherapy Efficacy in T-Cell Lymphoma
DNA Topoisomerase II-Mediated Interaction of Doxorubicin and Daunorubicin Congeners with DNA1
Investigation of the Mechanism of the Reduction of Anthracycline-Induced Cardiotoxicity by Qishen Huanwu Capsule Based on Network Pharmacology
Topoisomerase II Inhibitors
Bruton's Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib
Anthracyclines and Heart Failure Douglas B
Herceptin, INN-Trastuzumab
Selection of Optimal Adjuvant Chemotherapy And
DRUG NAME: Doxorubicin
(AC) Or Epirubicin and Cyclophosphamide (EC) Given 2 Weekly with Pegfilgrastim (Accelerated) Vs 3 Weekly (Standard) for Women with Early Breast Cancer
A Novel Anthracycline Producing DNA Interstrand Cross-Linking and Rapid Endonucleolytic Cleavage in Human Leukemia Cells1
Targeting Anthracyclines in Early Breast Cancer: New Candidate Predictive Biomarkers Emerge
Efficacy of Central Nervous System Prophylaxis with Stand-Alone
Four Cycles of Docetaxel-Cyclophosphamide